EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Hepatocyte TrkB Acts as a Gatekeeper Against MASH ‐Related Liver Fibrosis by Suppressing the TGFβ / CCL2 Axis and Macrophage Infiltration

Yueying Chen, Jiayi Wei, Shuxuan Li, Kefan Yin, Heming Wang iD, Yicheng Zhao iD, Shuqiang Weng, Xizhong Shen, Guangqi Song, Changfeng Zhu iD, Qunyan Yao, Ling Dong iD

Cell Proliferation · 2026-08 · 59 (8)

DOI: 10.1111/cpr.70202 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cell Proliferation, online erschienen am 03.04.2026. Verfasst von Yueying Chen und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology and Hepatology, Zhongshan Hospital, Fudan University, Shanghai, China. Hauptthemen laut MEDLINE: Macrophages, Liver Cirrhosis, Transforming Growth Factor beta, Chemokine CCL2. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Science Foundation of China, Shanghai Science and Technology Committee, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Liver fibrosis represents a critical pathological stage in chronic liver disease, characterized by excessive activation of hepatic stellate cells ( HSCs ) and dysregulated immune cell recruitment. Our previous studies demonstrated that overexpressing tyrosine kinase receptor B ( TrkB ) in HSCs inhibits their activation, thereby alleviating liver fibrosis. However, its functional significance in hepatocytes—the predominant parenchymal cells orchestrating liver homeostasis—remains poorly understood. Here, we investigate the mechanistic interplay between hepatocyte‐specific TrkB signalling and liver fibrosis progression. Through integrated in vivo animal models and in vitro two‐ and three‐dimensional systems, we demonstrate that elevated TrkB expression in hepatocytes reduces pro‐fibrotic and inflammatory cytokines, attenuates HSC activation via paracrine signalling, and impairs monocyte‐derived macrophage ( MoMF ) recruitment. Mechanistically, TrkB modulates the TGFβ / SMAD3 pathway by inhibiting p‐ SMAD3 nuclear translocation, thus suppressing FOS transcription. As a core component of the AP ‐1 transcription factor complex, FOS directly regulates CCL2 , a pivotal chemokine for macrophage recruitment. Collectively, these results establish TrkB as a key regulatory node in the TGFβ / SMAD3 / FOS / CCL2 signalling cascade, orchestrating macrophage‐mediated fibrotic responses in the liver.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MacrophagesLiver CirrhosisTransforming Growth Factor betaChemokine CCL2HepatocytesReceptor, trkBMembrane GlycoproteinsProtein-Tyrosine KinasesAnimalsSignal TransductionHepatic Stellate CellsMiceSmad3 ProteinMice, Inbred C57BLHumansMale

Stichwörter der Autor:innen

3D modelMoMFs recruitmentTrkBliver fibrosis

Substanzen

Transforming Growth Factor betaChemokine CCL2Receptor, trkBSmad3 ProteinMembrane GlycoproteinsProtein-Tyrosine KinasesNtrk2 protein, mouseCcl2 protein, mouse

Autor:innen und Institutionen

  • Department of Gastroenterology and Hepatology, Zhongshan Hospital, Fudan University, Shanghai, China.
  • Shanghai Institute of Liver Diseases, Shanghai, China.
  • Department of Oncology, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Department of Gastroenterology, Huadong Hospital, Shanghai Medical College, Fudan University, Shanghai, China.
  • Joint Laboratory of Biomaterials and Translational Medicine, Puheng Biomedicine Co., Ltd, Shanghai, China.
  • Chinese Medicine Guangdong Laboratory/State Key Laboratory of Traditional Chinese Medicine Syndrome, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine (Guangdong Provincial Hospital of Chinese M…

ORCID-Profile: Heming Wang, Yicheng Zhao, Changfeng Zhu, Ling Dong

Förderung

  • National Science Foundation of China
  • Shanghai Science and Technology Committee
  • National Natural Science Foundation of China
  • Science and Technology Commission of Shanghai Municipality

Zitieren

APA

Chen, Y., Wei, J., Li, S., Yin, K., Wang, H., Zhao, Y., Weng, S., Shen, X., Song, G., Zhu, C., Yao, Q., & Dong, L. (2026). Hepatocyte TrkB Acts as a Gatekeeper Against MASH ‐Related Liver Fibrosis by Suppressing the TGFβ / CCL2 Axis and Macrophage Infiltration. Cell Proliferation, 59(8). https://doi.org/10.1111/cpr.70202

Vancouver

Chen Y, Wei J, Li S, Yin K, Wang H, Zhao Y, et al. Hepatocyte TrkB Acts as a Gatekeeper Against MASH ‐Related Liver Fibrosis by Suppressing the TGFβ / CCL2 Axis and Macrophage Infiltration. Cell Proliferation. 2026;59(8). doi:10.1111/cpr.70202

BibTeX
@article{Chen2026,
  author = {Chen, Yueying and Wei, Jiayi and Li, Shuxuan and Yin, Kefan and Wang, Heming and Zhao, Yicheng and Weng, Shuqiang and Shen, Xizhong and Song, Guangqi and Zhu, Changfeng and Yao, Qunyan and Dong, Ling},
  title = {Hepatocyte TrkB Acts as a Gatekeeper Against MASH ‐Related Liver Fibrosis by Suppressing the TGFβ / CCL2 Axis and Macrophage Infiltration},
  journal = {Cell Proliferation},
  year = {2026},
  volume = {59},
  number = {8},
  doi = {10.1111/cpr.70202}
}
Kostenlos starten →